Effective Cannabis | Research & Blog
Tumors that start in the brain are called primary brain tumors. A tumor that starts in another part of the body and spreads to the brain is called a metastatic brain tumor.
In 2004, this studty exaimened Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Brain tumors Human Glioma Cell Lines. Utilizing human glioma cells. BACKGROUND: in a final set of experiments we evaluated the ability of in vivo CBD to reduce tumor growth. You can read the full article here => http://jpet.aspetjournals.org/content/308/3/838.long
In 2006, the first clinical study aimed at assessing cannabinoid antitumoral action, specifically a pilot phase in which nine patients with recurrent glioblastoma multiforme were administered THC. Background: Patients had previously failed standard therapy (surgery and radiotherapy) and had clear evidence of tumour progression. The primary end point of the study was to determine the safety .. Read More
In 2017, Brain tumors, Cannabis and Cannabinoids BACKGROUND: A review of 34 studies of cannabinoids in glioma tumor models found all but one study showed that cannabinoids can kill cancer cells without harming normal cells. You can read the full article here => https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq#section/_3
In 2017, Herb provided a guide to understanding cannabis and cancer treatment. Background: Here’s a guide to give an understanding of cannabis and cancer treatment. Covering the Top 10 cancers – Brain cancer, Breast cancer, Colon cancer, Hodgkin’s Lymphoma, Leukemia, Liver cancer, Lung cancer, Prostate cancer, Stomach cancer & Skin cancer. You can read the full article here => https://herb.co/marijuana/news/cannabis-cancer-treatment
In 2011, A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.Tumors were induced in nude mice BACKGROUND: The present work was therefore undertaken to study the potential synergic antitumoral action of TMZ (the benchmark agent for the management of GBM) and THC and CBD. Mice were assigned randomly to various groups and injected peritumorally for .. Read More
In 2004, Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines BACKGROUND: study to evaluate the in vitro antiproliferative ability of cannabidiol (CBD), a nonpsychoactive cannabinoid compound, on U87 and U373 human glioma cell lines. You can read the full article here => http://jpet.aspetjournals.org/content/308/3/838
In 2001, Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity BACKGROUND: We show in a longitudinal magnetic resonance imaging study that Δ9-tetrahydrocannabinol (Δ9-THC), the main active compound in marijuana, reduces neuronal injury in neonatal rats injected intracerebrally with the Na+/K+-ATPase inhibitor ouabain to elicit excitotoxicity. You can read the full article here .. Read More
In 2001, Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor BACKGROUND: Here we show that local administration of the selective CB2 agonist JWH-133 at 50 μg/day to Rag-2−/− mice induced a considerable regression of malignant tumors generated by inoculation of C6 glioma cells. Cannabinoid receptor expression was subsequently examined in biopsies from human astrocytomas You can .. Read More
in 2006, A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme BACKGROUND: Here we report the first clinical study aimed at assessing cannabinoid antitumoral action, specifically a pilot phase I trial in which nine patients with recurrent glioblastoma multiforme were administered THC intratumoraly. You can read the full article here => https://www.nature.com/articles/6603236
